HOME Research Insight Product Launches is the Key Growth Strategy Adopted by Players Operating in the Global Pharmaceutical Filtration Market



Product Launches is the Key Growth Strategy Adopted by Players Operating in the Global Pharmaceutical Filtration Market


Merck KGaA (Germany), GE Healthcare (U.S.), and Pall Corporation (U.S.) are the leading players in the global pharmaceutical filtration market. The strong position of these companies in the market can primarily be attributed to their global presence and broad product portfolio. Other major players in the market include Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France), 3M Company (U.S.), Eaton Corporation Plc (Ireland), Amazon Filters Ltd. (U.K.), Graver Technologies, LLC (U.S.), and Meissner Filtration Products, Inc. (U.S.).

Merck KGaA dominated the global pharmaceutical filtration market in 2015. The company offers pharmaceutical filters through its life sciences business segment, which cater to the markets in developed as well as developing countries. The company mainly focuses on product launches and expansions as its key growth strategies. The company serves the markets with its leading products such as the Viresolve Pro Shield H, Aervent (PTFE), Durapore (PVDF), and Millipore Express (PES) membranes. In January 2017, the company expanded in Boston and Massachusetts (U.S.), Shanghai (China), and Martillac (France) by establishing end-to-end bio-development centers to strengthen its global footprint.

GE Healthcare held the second position in the global pharmaceutical filtration market in 2015. GE Healthcare operates under three business segments, namely, Healthcare Systems, Life Sciences, and Healthcare IT. The company focuses on acquisitions, expansions, and agreements to keep up with its competitors. In September 2016, GE Healthcare Life Sciences opened a GE Fast Track Center in South Korea. In October 2015, GE acquired IMT Solutions, a Netherlands-based manufacturer of ultrafiltration and microfiltration membranes for water treatment. GE offers a broad portfolio of pharmaceutical filters and has a vast geographic presence with distribution channels across the Americas, Europe, Asia, and the Middle East & Africa.

Pall Corporation, a subsidiary of Danaher Corporation, held the third position in the global pharmaceutical filtration market in 2015. The company offers its pharmaceutical filtration solutions through Danaher’s Life Sciences and Diagnostics business segment. It focuses mainly on the strategy of product launches to enhance its technical strengths as well as secure its market position. The company launched Pegasus Prime Virus Removal Filters in October 2016, and Cadence Acoustic Separator (CAS), an acoustic wave separation technology for clarification of cell cultures in April 2016. The company has a global presence in developed regions such as North America and Europe as well as developing regions such as Asia-Pacific, Africa, and South America.

Companies in the pharmaceutical filtration market are focusing on product launches for strengthening their market share; this strategy accounted for 39.5% of the total number of strategic developments undertaken by key players in this market.

Related Reports:

Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports